Health11 years ago
FDA Approves Amgen’s Heart-Failure Drug Corlanor
(USA Today) – The U.S. Food and Drug Administration on Wednesday approved Amgen Inc.’s heart-failure treatment Corlanor, which had been designated for priority review in August. The...
